Shukra Pharmaceuticals Announces 33rd AGM on Sep 28, 2026

Shukra Pharmaceuticals Ltd has issued a notice for its 33rd Annual General Meeting (AGM) to be held on September 28, 2026, at 12:00 P.M. IST via Video Conferencing. The agenda includes the adoption of audited financial statements for the fiscal year ended March 31, 2026, and the declaration of a final dividend of 1% (₹0.01 per equity share). Additionally, the meeting will address the re-appointment of Ms. Sanskruti Patel as an Executive Director and the regularization of Mr. Dinesh Chauhan's appointment as an Additional Independent Director.